Update shared on08 Oct 2025
Fair value Decreased 2.17%Analysts have slightly lowered their price target for Blackbaud from $76.83 to $75.17. This reflects a modest shift in valuation based on updated financial assumptions.
What's in the News
- Blackbaud unveiled a new suite of embedded AI capabilities at bbcon 2025, including its agentic AI platform, Agents for Good. This platform enables social impact teams to automate workflows and reach more donors. The company also helped launch the AI Coalition for Social Impact to support responsible AI adoption across the sector. (Key Developments)
- Significant updates to Blackbaud Impact Edge, its AI-powered social impact reporting tool, now offer smarter analytics, a Charity Discovery Tool powered by Candid and True Impact, and enhanced dashboards to help companies assess the impact of donations and volunteering. (Key Developments)
- Improvements to Blackbaud’s K-12 Education Management portfolio add new features to streamline teacher workflows, enhance parent engagement and improve the digital classroom experience. (Key Developments)
- Blackbaud raised its full-year 2025 financial guidance, forecasting GAAP revenue between $1.120 billion and $1.130 billion. (Key Developments)
- The company reported completion of its share repurchase program, with 9,404,230 shares repurchased for $687.12 million under the buyback plan started in 2010. (Key Developments)
Valuation Changes
- Consensus Analyst Price Target has decreased slightly from $76.83 to $75.17.
- Discount Rate has risen modestly, moving from 9.46% to 9.60%.
- Revenue Growth projections remain virtually unchanged at 3.19%.
- Net Profit Margin forecasts are stable, holding steady at approximately 11.41%.
- Future P/E ratio expectations have declined slightly from 29.58x to 29.05x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.